John G. Cox
Board Member
Dyne Therapeutics, Inc. (DYN)Equibles does not estimate personal net worth.
Get an email with a short summary when Dyne Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DYN alertsAbout John G. Cox
John G. Cox is recorded as Board Member and CEO at Dyne Therapeutics, Inc. (DYN). The newest filing on record that lists John G. Cox as Board Member and CEO at Dyne Therapeutics, Inc. (DYN) is dated April 23, 2026. John G. Cox was last confirmed as Board Member at Repligen Corp (RGEN) in a filing dated April 28, 2020. The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $2,076,868 for John G. Cox in fiscal 2025, including a base salary of $721,000. Disclosed compensation is on record for 2 fiscal years. Dyne Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dyne Therapeutics, Inc. includes John Cox (CEO and Board Member), Josh Brumm (CEO), Erick Lucera (CFO and Chief Accounting Officer) and 4 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 23, 2026
-
Current
Start not stated–present
Last confirmed April 23, 2026
-
Start not stated–2020-04-28
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Dyne Therapeutics, Inc.
- John Cox CEO, Board Member
- Josh Brumm CEO
- Erick Lucera CFO, Chief Accounting Officer
- Barry E. Greene Board Member
- Brian Posner Board Member
- Carlo Incerti, M.D. Board Member
- Vikram Karnani Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dyne Therapeutics, Inc. (DYN) | President and Chief Executive Officer | $721,000 | $2,076,868 |
| 2024 | Dyne Therapeutics, Inc. (DYN) | President and Chief Executive Officer | $536,986 | $20,688,724 |
Recent activity
No call appearances or filed executive changes recorded yet.